Kavlie A - Search Results

1

r84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity induction.

Sullivan LA, Carbon JG, Roland CL, Toombs JE, Nyquist-Andersen M, Kavlie A, Schlunegger K, Richardson JA, Brekken RA. Sullivan LA, et al. Among authors: kavlie a. PLoS One. 2010 Aug 6;5(8):e12031. doi: 10.1371/journal.pone.0012031. PLoS One. 2010. PMID: 20700512 Free PMC article.

2

A novel angiopoietin-2 selective fully human antibody with potent anti-tumoral and anti-angiogenic efficacy and superior side effect profile compared to Pan-Angiopoietin-1/-2 inhibitors.

Thomas M, Kienast Y, Scheuer W, Bähner M, Kaluza K, Gassner C, Herting F, Brinkmann U, Seeber S, Kavlie A, Welschof M, Ries S, Weidner KM, Regula JT, Klein C. Thomas M, et al. Among authors: kavlie a. PLoS One. 2013;8(2):e54923. doi: 10.1371/journal.pone.0054923. Epub 2013 Feb 6. PLoS One. 2013. PMID: 23405099 Free PMC article.

3

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines.

Moody MA, Liao HX, Alam SM, Scearce RM, Plonk MK, Kozink DM, Drinker MS, Zhang R, Xia SM, Sutherland LL, Tomaras GD, Giles IP, Kappes JC, Ochsenbauer-Jambor C, Edmonds TG, Soares M, Barbero G, Forthal DN, Landucci G, Chang C, King SW, Kavlie A, Denny TN, Hwang KK, Chen PP, Thorpe PE, Montefiori DC, Haynes BF. Moody MA, et al. Among authors: kavlie a. J Exp Med. 2010 Apr 12;207(4):763-76. doi: 10.1084/jem.20091281. Epub 2010 Apr 5. J Exp Med. 2010. PMID: 20368576 Free PMC article.

4

The influence of the -401G/T and -402G/A polymorphisms of the coagulation FVII promoter on plasma levels of FVII.

Lindman AS, Pedersen JI, Hjerkinn EM, Veierød MB, Kavlie A, Arnesen H, Seljeflot I. Lindman AS, et al. Among authors: kavlie a. Thromb Res. 2005;116(4):313-20. doi: 10.1016/j.thromres.2004.08.031. Epub 2005 Jan 21. Thromb Res. 2005. PMID: 16038716 No abstract available.

5

Construction, evaluation and refinement of a large human antibody phage library based on the IgD and IgM variable gene repertoire.

Løset GÅ, Løbersli I, Kavlie A, Stacy JE, Borgen T, Kausmally L, Hvattum E, Simonsen B, Hovda MB, Brekke OH. Løset GÅ, et al. Among authors: kavlie a. J Immunol Methods. 2005 Apr;299(1-2):47-62. doi: 10.1016/j.jim.2005.01.014. Epub 2005 Mar 8. J Immunol Methods. 2005. PMID: 15914190

6

A novel gene mutation in the 60s loop of human coagulation factor VII - inhibition of interdomain crosstalk.

Kavlie A, Wiiger MT, Husbyn M, Stormorken H, Prydz H. Kavlie A, et al. Thromb Haemost. 2004 Jan;91(1):28-37. doi: 10.1160/TH03-05-0258. Thromb Haemost. 2004. PMID: 14691565

7

Two novel mutations in the human coagulation factor VII promoter.

Kavlie A, Hiltunen L, Rasi V, Prydz H. Kavlie A, et al. Thromb Haemost. 2003 Aug;90(2):194-205. doi: 10.1160/TH02-09-0050. Thromb Haemost. 2003. PMID: 12888866

8

Homozygous Q100R mutations in the second EGF-like domain of factor VII.

Kavlie A, Prydz H. Kavlie A, et al. Blood. 1999 Dec 1;94(11):3960. Blood. 1999. PMID: 10627125 Free article. No abstract available.

9

Characterization of a factor VII molecule carrying a mutation in the second epidermal growth factor-like domain.

Kavlie A, Orning L, Grindflek A, Stormorken H, Prydz H. Kavlie A, et al. Thromb Haemost. 1998 Jun;79(6):1136-43. Thromb Haemost. 1998. PMID: 9657438

10

Extensive intimal apolipoprotein A1-derived amyloid deposits in a patient with an apolipoprotein A1 mutation.

Amarzguioui M, Mucchiano G, Häggqvist B, Westermark P, Kavlie A, Sletten K, Prydz H. Amarzguioui M, et al. Among authors: kavlie a. Biochem Biophys Res Commun. 1998 Jan 26;242(3):534-9. doi: 10.1006/bbrc.1997.8005. Biochem Biophys Res Commun. 1998. PMID: 9464251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page